Severe Acute Thrombocytopenia After Biosimilar Trastuzumab Administration: A Case Report
Journal of Pharmacy and Pharmacology Research(2020)
Abstract
Drug-induced immune thrombocytopenia may occur secondary to several chemotherapeutic agents or new targeted monoclonal antibodies, but thrombocytopenia induced by trastuzumab is a very rare occurrence. We report a case of severe thrombocytopenia related to the first administration of a biosimilar trastuzumab, trastuzumab rechallenge was undertaken with the reference trastuzumab without other problems.
MoreTranslated text
Key words
severe acute thrombocytopenia,biosimilar trastuzumab administration
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined